Leonard G. Gomella, MD, chairman of the Department of Urology at the Sidney Kimmel Cancer Center, discusses emerging biomarkers and the use of MRI for the early detection of prostate cancer.
Adding SBRT to frontline abiraterone shows benefit in oligometastatic CRPC
September 25th 2023The addition of SBRT to upfront abiraterone acetate and prednisone (AAP) reduced the risk of disease progression or death by 65% compared with AAP alone in patients with oligometastatic castration-resistant prostate cancer.
2 Clarke Drive
Cranbury, NJ 08512